25 of the Best Oncologists Near Me

Dr. Talpaz comes to U-M from the University of Texas M.D. Anderson Cancer Center in Houston, where he was a professor of medicine. His research interests include the study of leukemia and immunotherapy, which uses the immune system to fight cancer. He also treats patients with leukemia. Talpaz will continue his research, expanding the U-M Rogel Cancer Center's efforts in hematologic cancer. He will serve as professor of internal medicine at the U-M Medical School. Dr. Talpaz is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Chronic Myelogenous Leukemia (CML), Myeloproliferative Neoplasms (MPN), Philadelphia-Negative Chronic Myeloid Leukemia, and Childhood Acute Myeloid Leukemia. Dr. Talpaz is board certified in Internal Medicine and Medical Oncology. Dr. Talpaz is currently accepting new patients.

Dr. Hala Borno is a medical oncologist who cares for patients who have cancers along the urinary tract, including kidney, bladder, testicular and prostate cancer. She specializes in treating prostate cancer. Borno's research focuses on improving access to cancer clinical trials and digital health innovation. Borno earned her medical degree from the University of North Carolina at Chapel Hill School of Medicine. She completed a residency in internal medicine and a fellowship in medical oncology at UCSF, where she was selected chief oncology fellow. She is a member of the American Society of Clinical Oncology and Alliance for Clinical Trials in Oncology. Dr. Borno is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Familial Wilms Tumor 2, Renal Cell Carcinoma (RCC), and Orchiectomy. Dr. Borno is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Borno is currently accepting new patients.

Dr. Schott is a Professor of Medicine and is the Associate Director of Clinical Research for the Rogel Cancer Center. She is an expert in the field of breast cancer, has an active breast cancer practice, and frequently gives lectures and publishes about breast cancer treatment. Her research is focused on the development of new treatments for breast cancer, and the testing of these treatments in clinical trials. Dr. Schott is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Inflammatory Breast Cancer, Angiosarcoma, HER2 Negative Breast Cancer, and Tissue Biopsy. Dr. Schott is currently accepting new patients.

Christopher Dvorak is a Hematologist and an Oncologist practicing medicine in San Francisco, California. Dr. Dvorak is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Hepatic Venoocclusive Disease with Immunodeficiency, Graft Versus Host Disease (GvHD), Primary Immunodeficiency (PID), Bone Marrow Transplant, and Splenectomy.

Richard Fisher is an Oncologist practicing medicine in Philadelphia, Pennsylvania. Dr. Fisher is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Diffuse Large B-Cell Lymphoma (DLBCL), Lymphadenectomy, and Prostatectomy.

Nithya Ramnath is an Oncologist and a Hematologist practicing medicine in Ann Arbor, Michigan. Dr. Ramnath is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Lung Adenocarcinoma, and Pleuropulmonary Blastoma. Dr. Ramnath is currently accepting new patients.

Dr. Green is a Professor of Medicine and Chief of the Division of Transplantation and Cellular Therapy at the University of Miami. He also serves as the Assistant Director of Translational Research for the Sylvester Comprehensive Cancer Center. Dr. Green has over 20 years of experience treating patients with blood cancers while maintaining a specialized focus on multiple myeloma, B cell lymphoma, stem cell transplant and immunotherapy. His research involves harnessing the power of the immune system to directly target cancer cells while protecting healthy cells from injury. In his laboratory, he has developed numerous immunotherapy approaches for first-in-human clinical trials. Dr. Green is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Non-Hodgkin Lymphoma, B-Cell Lymphoma, Bone Marrow Transplant, and Gastrostomy. Dr. Green is currently accepting new patients.

Michael Rosenzweig is an Oncologist practicing medicine in Duarte, California. Dr. Rosenzweig is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Transthyretin Amyloid Cardiomyopathy, and Bone Marrow Aspiration.

Josephine (Joy) Feliciano, M.D., is an assistant professor of oncology at The Johns Hopkins University School of Medicine and a faculty member of the Johns Hopkins Kimmel Cancer Center. She serves as medical director of the Thoracic Oncology Program at Johns Hopkins Bayview Medical Center, as well as co-director of the outpatient oncology clinic at Johns Hopkins Bayview. Dr. Feliciano completed both undergraduate and postgraduate medical training at Georgetown University, as well as residency training, where she was selected as chief resident. She spent three years at Northwestern completing clinical training in hematology and oncology, then joined the faculty at University of Maryland Greenberg Cancer Center. At the University of Maryland, Feliciano focused on lung cancer screening and health disparities research for patients with lung cancer. While there, she also earned a certificate degree in the Epidemiology and Human Genetics Program for Clinical Investigation. Dr. Feliciano is also a member of the Miller Coulson Academy of Clinical Excellence. She also serves as the inaugural Medical Director of the Sidney Kimmel Cancer Diagnostic and Treatment Planning Center. Dr. Feliciano is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Squamous Cell Lung Carcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Pleuropulmonary Blastoma. Dr. Feliciano is board certified in American Board Of Internal Medicine. Dr. Feliciano is currently accepting new patients.

Leslie Fecher, MD, joined the faculty on from Indiana University School of Medicine's Simon Cancer Center. Dr. Fecher completed her BA in Biochemistry at Rice University in Houston, and earned her MD from Indiana University School of Medicine. She completed her residency at University of Texas Southwestern in Dallas, followed by an Oncology Fellowship at Johns Hopkins' Sidney Kimmel Comprehensive Cancer Center in Baltimore. Dr. Fecher was an assistant professor of medicine at the Abramson Cancer Center in Philadelphia for four years where she held a secondary appointment in Dermatology. She subsequently joined the faculty at Indiana University in 2011. Dr. Fecher is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Melanoma, Merkel Cell Carcinoma, Melanoma of the Eye, Metastatic Uveal Melanoma, and Tissue Biopsy. Dr. Fecher is currently accepting new patients.

Mary Flowers is a Hematologist and an Oncologist practicing medicine in Seattle, Washington. Dr. Flowers is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Transplant.

Ian Anderson is a Hematologist Oncology specialist and an Oncologist practicing medicine in Santa Rosa, California. Dr. Anderson is highly rated in 59 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Small Cell Lung Cancer (SCLC), Pleuropulmonary Blastoma, Lung Adenocarcinoma, and Bone Marrow Aspiration. Dr. Anderson is currently accepting new patients.

Shannon L. Puhalla, MD, is assistant professor of medicine at the University of Pittsburgh School of Medicine, and a medical oncologist and hematologist at UPMC Hillman Cancer Center. She specializes in breast oncology, Phase I clinical trials, and novel therapeutics in breast cancer. Dr. Puhalla is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Inflammatory Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Breast Cancer. Dr. Puhalla is board certified in American Board Of Internal Medicine and American Board Of Internal Medicine. Dr. Puhalla is currently accepting new patients.

Alok Pant is an Oncologist practicing medicine in Lake Forest, Illinois. Dr. Pant is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Malignant Mixed Mullerian Tumor, Testicular Yolk Sac Tumor, and Ovarian Cancer. Dr. Pant is board certified in American Board Of Obstetrics And Gynecology - Gynecologic Oncology (Certified). Dr. Pant is currently accepting new patients.

Mark H. Einstein, MD, is the Chella & Moise Safra Endowed Chair and Department Chair, Obstetrics & Gynecology and Women’s Health at Montefiore Einstein and Professor, Obstetrics & Gynecology and Women’s Health at our Albert Einstein College of Medicine. Dr. Einstein is an internationally renowned expert in gynecologic oncology and gynecologic cancer prevention. He is very active clinically and manages complicated gynecologic precancers and malignancies using state-of-the-art evidence-based clinical and surgical strategies. He also leads and offers clinical trial options. Dr. Einstein is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Cervical Cancer, Anal Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, and Endoscopy. Dr. Einstein is currently accepting new patients.

Erin Jepsen is an Oncologist and a Hematologist practicing medicine in Winston Salem, North Carolina. Dr. Jepsen is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Familial Colorectal Cancer. Dr. Jepsen is currently accepting new patients.

Dr. Kelly received his medical degree from the Royal College of Surgeons in Ireland in 1998. He completed his internship, residency and oncology fellowship from the Royal College of Physicians in Ireland in 2007. Dr. Kelly completed a second fellowship in medical oncology at the National Cancer Institute (NCI) in Bethesda MD from 2007–2009 and continued as a clinical researcher in thoracic oncology at the NCI until moving to Johns Hopkins in 2011. At Johns Hopkins, Dr. Kelly was the director of the gastroesophageal cancer therapeutics program and also served as the director of global oncology for Johns Hopkins International. Dr. Kelly was recruited as the Director of Oncology for the Charles A. Sammons Cancer Center and the Chief of Oncology for the North Texas Division of the BSWH system in 2018. Dr. Kelly performs translational and clinical research encompassing the discovery and the development of new targeted and immunotherapeutic approaches in the prevention and treatment of gastroesophageal cancer and lung cancer and he is the International principal investigator on a number of global phase II/III clinical trials in these disease areas. In addition he is leading efforts nationally and internationally to design quality metrics for solid tumors and implementing value-based algorithms to help bend the cost curve in the United States. At the Charles A. Sammons Cancer Center he also helps to co-lead the Innovative Clinical Trials Center which investigates novel therapeutics across a range of tumor types. He serves as the co-chair of the International Association for the Study of Lung Cancer (IASLC) and the American Society of Clinical Oncology (ASCO) taskforce working to improve the quality of care received by lung cancer patients worldwide. He is an active member of ASCO and the Eastern Cooperative Oncology group. He is a founding member of the International Quality Oncology Taskforce in ASCO and serves on the ASCO measures taskforce, the clinical practice committee and the lung cancer quality taskforce. He has authored and co-authored over 150 peer-reviewed publications, abstracts and book chapters, and contributed his work to many prominent healthcare journals. Dr. Kelly’s leadership of oncology services spans Baylor Scott & White’s footprint in the Dallas-Fort Worth area, which includes Baylor University Medical Center—the System’s North Texas flagship hospital and one of the largest cancer hospitals in the nation—as well as a network of 11 Baylor Charles A. Sammons Cancer Centers throughout Texas. Publications. Dr. Kelly is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Gastroesophageal Junction Cancer, Non-Small Cell Lung Cancer (NSCLC), Pancreaticoduodenectomy, and Tissue Biopsy. Dr. Kelly is board certified in - American Board Of Internal Med/Medical Oncology, Internal Medicine- American Board Of Internal Med/Medical Oncology, - American Board Of Internal Med, Medical Oncology- American Board Of Internal Medicine, Internal Medicine- American Board Of Internal Med, and Internal Medicine- American Board Of Internal Medicine. Dr. Kelly is currently accepting new patients.

Dr. Maisel specializes in hematologic malignancies, benign hematology, multiple myeloma, myelodysplasia, lymphoma and bleeding disorders.He attended medical school at the University of Pittsburgh School of Medicine in Pennsylvania. He then completed an Internal Medicine residency at Ohio State University Hospital in Columbus, OH and a Hematology/Oncology fellowship at Case Western Reserve University in Cleveland, OH.Dr. Maisel enjoys hiking, fitness, travel and reading about history. Dr. Maisel is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Aplastic Anemia, Smoldering Multiple Myeloma, and Bone Marrow Aspiration. Dr. Maisel is board certified in Hematology- American Board Of Internal Med/Hematology, Internal Medicine- American Board Of Internal Med, Internal Medicine- American Board Of Internal Medicine, and Hematology- American Board Of Internal Medicine. Dr. Maisel is currently accepting new patients.

Dr. Lam treats patients with lung cancer, esophageal cancer, mesothelioma, and other thoracic cancers. He directs the Thoracic Oncology Clinical Research Program and the Esophageal Cancer Research Program at Johns Hopkins. Dr. Lam is a clinical and translational researcher with a focus on cancer genomics, liquid biopsies, and novel immunotherapies such as vaccines and cell therapies. He has been recognized with a Conquer Cancer Foundation/ASCO Career Development Award, an LCFA/IASLC/BMS Young Investigator Award, and as a Gilead Research Scholar. Dr. Lam is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, and Small Cell Lung Cancer (SCLC). Dr. Lam is currently accepting new patients.

Dr. McCormick sees patient education as an important part of her job. “I want each of my patients to understand their diagnosis and treatment options so that together we can formulate a plan tailored to their unique goals and priorities.” Dr. McCormick also believes in ensuring that her patients have access to the most state-of-the-art medical care, including the option of participating in promising clinical trials. Finally, Dr. McCormick values a team-based approach. “I appreciate that receiving a cancer diagnosis can be scary and stressful. I am fortunate to work with an amazing team of nurses, social workers, nutritionists, genetic counselors and many others who help to support our patients through this journey.”. Dr. Mccormick is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Paget Disease of the Breast, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Mccormick is board certified in American Board Of Internal Medicine. Dr. Mccormick is currently accepting new patients.

I am a medical oncologist who primarily focuses on treating breast cancer. I’ve been at Duke Raleigh since 2007, and I also serve as the hospital’s chief medical officer. My favorite part of my job is the initial patient visit. It’s not unusual for patients to arrive for their appointment feeling fearful and anxious. I enjoy making them feel more comfortable and at ease with their diagnosis and treatment plan by the end of the visit. To further build that bond and trust, I encourage my patients to have full access to me, even on weekends or holidays, so I can help guide their treatment. I decided to become a doctor when I was 18 years old and heading to college. I felt that I would be passionate about taking care of people and my intuition turned out to be right. I am married to a physician and my oldest son is a medical school graduate, so medicine is now firmly in my family’s blood. Dr. Spiritos is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Angiosarcoma, and Inflammatory Breast Cancer. Dr. Spiritos is board certified in American Board Of Internal Med, Internal Medicine and American Board Of Internal Med, Medical Oncology. Dr. Spiritos is currently accepting new patients.

John T. Comerci, MD, is a surgical oncologist, director of Gynecologic Oncology at UPMC Passavant Hospital, and associate professor at the University of Pittsburgh School of Medicine. His expertise is in robotic surgery and the diagnosis and management of diseases of the female reproductive organs, including ovarian, uterine, cervical, and vulvar cancers. His research interests include photodynamic therapy in the treatment of cervical and ovarian cancer. Dr. Comerci is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Endometrial Cancer, Ovarian Cancer, Malignant Mixed Mullerian Tumor, Testicular Yolk Sac Tumor, and Vulvectomy. Dr. Comerci is board certified in American Board Of Obstetrics And Gynecology and American Board Of Obstetrics And Gynecology. Dr. Comerci is currently accepting new patients.

Kartik Sehgal is an Oncologist practicing medicine in Boston, Massachusetts. Dr. Sehgal is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Anaplastic Thyroid Cancer, Thyroid Cancer, Medullary Thyroid Carcinoma, and Head and Neck Squamous Cell Carcinoma (HNSCC). Dr. Sehgal is board certified in Internal Medicine and Medical Oncology. Dr. Sehgal is currently accepting new patients.

Nusrat Chaudhary is an Oncologist and a Hematologist practicing medicine in Matthews, North Carolina. Dr. Chaudhary is highly rated in 9 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma. Dr. Chaudhary is board certified in Internal Medicine. Dr. Chaudhary is currently accepting new patients.

Mohamed Salem is an Oncologist practicing medicine in Charlotte, North Carolina. Dr. Salem is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Colorectal Cancer, Familial Colorectal Cancer, Neuroendocrine Tumor, and Lynch Syndrome. Dr. Salem is currently accepting new patients.